News
RELX
35.68
+2.79%
0.97
Weekly Report: what happened at RELX last week (0406-0410)?
Weekly Report · 2d ago
Citigroup Upgrades RELX to Buy
Benzinga · 04/08 13:45
LexisNexis finds global fraud rate rises 8% as synthetic identity attacks surge
Reuters · 04/08 13:07
Synthetic Identities and Agentic Bots Posing as Human Contribute to 8% Global Rise in Fraud Attacks - LexisNexis Risk Solutions
PR Newswire · 04/08 13:06
Relx upgraded to Buy from Neutral at Citi
TipRanks · 04/08 10:13
*RELX Raised to Buy From Neutral by Citigroup
Dow Jones · 04/08 08:52
*RELX Target Cut to GBP28.70 From GBP33.25 by Citigroup
Dow Jones · 04/08 08:52
Citi upgrades RELX plc (RLXXF) to a Buy
TipRanks · 04/08 08:15
EUROPE RESEARCH ROUNDUP-ASML Holding, Relx, Spie
Reuters · 04/08 07:31
Weekly Report: what happened at RELX last week (0330-0403)?
Weekly Report · 04/06 10:15
LexisNexis says global fraud attack rate rises 8% as agentic bots surge
Reuters · 03/31 08:30
Weekly Report: what happened at RELX last week (0323-0327)?
Weekly Report · 03/30 10:15
RELX launches GBP 350 million share buyback program through April 22, 2026
Reuters · 03/23 17:55
BRIEF-Relx Plc Announces Non-Discretionary Share Buyback Programme
Reuters · 03/23 12:22
Weekly Report: what happened at RELX last week (0316-0320)?
Weekly Report · 03/23 10:11
UK Stocks-Factors to watch on March 18 
Reuters · 03/18 05:24
BLOCK TRADE: GS DEAL - RELX BOOKS COVERED- BOOKRUNNER
Reuters · 03/17 17:25
Weekly Report: what happened at RELX last week (0309-0313)?
Weekly Report · 03/16 10:11
Emerald Holding: Selling The Buyout Rumor Paid Off (Rating Upgrade)
Seeking Alpha · 03/16 07:23
More
Webull provides a variety of real-time RELX stock news. You can receive the latest news about Relx Plc through multiple platforms. This information may help you make smarter investment decisions.
About RELX
RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.